Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2016	Apr. 02, 2015
Operating activities
Net income	$ 171.6	$ 181.9
Adjustments to reconcile net income to net cash provided by operating activities
Depreciation expense	49.4	43.6
Amortization expense	0.0	0.5
Amortization of deferred financing fees	1.1	4.2
Accretion of customer supply agreement	1.0	0.4
Employee stock compensation expense	5.3	6.9
Excess tax benefit of share-based payment arrangements	(0.3)	0.0
Loss (gain) from hedge contracts	0.0	1.6
Loss from foreign currency transactions	4.6	6.4
Gain (Loss) on Disposition of Property Plant Equipment	2.5	0.0
Deferred taxes	24.1	1.2
Increase (Decrease) in Pension and Postretirement Obligations	7.0	(6.1)
Grant income	(2.7)	(2.6)
Equity in net income of affiliate	(0.6)	(0.3)
Changes in assets and liabilities
Accounts receivable	(148.6)	0.3
Inventory, net	(50.6)	33.8
Accounts payable and accrued liabilities	19.9	(10.2)
Profit sharing/deferred compensation	(43.1)	(91.1)
Advance payments	(40.3)	(10.2)
Income taxes receivable/payable	58.2	198.0
Deferred revenue and other deferred credits	29.9	56.7
Other	5.4	8.7
Net cash provided by operating activities	93.8	423.7
Investing activities
Purchase of property, plant and equipment	(50.4)	(40.3)
Net cash used in investing activities	(50.4)	(40.3)
Financing activities
Proceeds from Issuance of Long-term Debt	0.0	535.0
Principal payments of debt	(7.5)	(7.5)
Repayments of Debt	0.0	(534.9)
Payments Related to Tax Withholding for Share-based Compensation	(2.9)	0.0
Excess tax benefit of share-based payment arrangements	0.2	0.0
Debt issuance and financing costs	0.0	(4.7)
Payments for Repurchase of Common Stock	(165.2)	0.0
Net cash used in financing activities	(175.4)	(12.1)
Effect of exchange rate changes on cash and cash equivalents	(2.4)	0.3
Net (decrease) increase in cash and cash equivalents for the period	(134.4)	371.6
Cash and cash equivalents, beginning of period	957.3	377.9
Cash and cash equivalents, end of period	$ 822.9	$ 749.5